Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wallace J Brownlee

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Neurology|May 3, 2019
Differential diagnosis of multiple sclerosis: The better explanations in clinical practiceWallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2025
Diagnostic and treatment challenges in patients at the borderlands of the idiopathic inflammatory demyelinating disordersWallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2022
Cladribine-induced liver injury: Implications for practiceWallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2018
Do spinal cord lesions matter in patients with clinically isolated syndrome and early MS?Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 12, 2019
Instead of tweaking the diagnostic criteria for MS in those with CIS, we should develop diagnostic criteria that distinguish MS from other conditions - NoWallace J Brownlee
Neurology|November 2, 2018
Misdiagnosis of multiple sclerosis: If you have a hammer, everything looks like a nail?Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2018
Clinical commentary on 'Late-onset neutropenia and neurological relapse during long-term rituximab therapy in MOG antibody spectrum disorder'Yael Hacohen, Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 15, 2017
Opportunistic infections after alemtuzumab: New cases of norcardial infection and cytomegalovirus syndromeWallace J Brownlee, Jeremy Chataway
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2025
Cladribine: A useful treatment option in multiple sclerosis patients with autoimmune comorbiditiesJoe Lu, Wallace J Brownlee
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Neurology|May 3, 2019
Differential diagnosis of multiple sclerosis: The better explanations in clinical practiceWallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2025
Diagnostic and treatment challenges in patients at the borderlands of the idiopathic inflammatory demyelinating disordersWallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2022
Cladribine-induced liver injury: Implications for practiceWallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2018
Do spinal cord lesions matter in patients with clinically isolated syndrome and early MS?Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 12, 2019
Instead of tweaking the diagnostic criteria for MS in those with CIS, we should develop diagnostic criteria that distinguish MS from other conditions - NoWallace J Brownlee
Neurology|November 2, 2018
Misdiagnosis of multiple sclerosis: If you have a hammer, everything looks like a nail?Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2018
Clinical commentary on 'Late-onset neutropenia and neurological relapse during long-term rituximab therapy in MOG antibody spectrum disorder'Yael Hacohen, Wallace J Brownlee
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 15, 2017
Opportunistic infections after alemtuzumab: New cases of norcardial infection and cytomegalovirus syndromeWallace J Brownlee, Jeremy Chataway
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2025
Cladribine: A useful treatment option in multiple sclerosis patients with autoimmune comorbiditiesJoe Lu, Wallace J Brownlee
Pageof 6